This grant is a new Cancer Center Support Grant application from the Vincent T. Lombardi Cancer Research Center (LCRC). The LCRC is a previously identified comprehensive cancer center of the National Cancer Institute. It previously enjoyed continuous funding as a cancer center by the NCI until its most recent renewal was approved but not funded. The current submission, a new application, represents the product of a complete reorganization of the LCRC with major new leadership, new personnel and new program building on an existing institutional framework. The LCRC, initially established in 1970 by the trustees of the University, is a comprehensive cancer center which is designed to promote interdisciplinary clinical and laboratory research throughout the University. It consists of twelve major program areas. Eight of these programs are multi-disciplinary involving laboratory and clinical investigations and four of the programs are primarily laboratory in nature. The multidisciplinary programs are AIDS, Breast Cancer, Experimental Therapeutics, Experimental Hematology and Bone Marrow Transplantation, Gastrointestinal Malignancies, Genitourinary Malignancies, Gynecologic Oncology, and Radiation Oncology. The four basic science research programs are ADP-Ribosylation and Repair of DNA Damage, Control of Invasion and Metastasis, Growth Regulation of Cancer, and Viral Oncology. The twelve programs as well as other investigations within the Cancer Center receive substantial support from seven shard basic resources that have been established by the Center. These include Recombinant Technology Peptide Synthesis and Sequencing, Flow Cytometry, Microscopy and Morphology, Animal Facility for Nude Mice Experimentation, Tumor Imaging, Biostatistics, and a Clinical Research Management Facility. The University has committed significant resources to the renewal and rededication of the Cancer Center including major salary support, discretionary authority for disbursement of funds, major salary support, discretionary authority for disbursement of funds, major renovation of space, and responsibility for coordinating all clinical and laboratory cancer related activities on the campus. The LCRC faculty of 136 receive over 8 million dollars annually in extramural support with more than 11 million dollars in grants pending. The achievements of the Cancer Center in the past have been substantial and the potential for the future of current programs and initiatives is extremely promising.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA051008-01
Application #
3101872
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1990-09-30
Project End
1993-04-30
Budget Start
1990-09-30
Budget End
1991-04-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Tassi, Elena; Lai, En Yin; Li, Lingli et al. (2018) Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein). Hypertension 71:160-167
Burks, Julian; Nadella, Sandeep; Mahmud, Abdullah et al. (2018) Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer. Cell Mol Gastroenterol Hepatol 6:17-32
Lelo, Alana; Prip, Frederik; Harris, Brent T et al. (2018) STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer. Clin Cancer Res 24:4145-4153
Choudhary, Saba; Ramasundaram, Poornema; Dziopa, Eugenia et al. (2018) Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer. Sci Rep 8:17975
Sponholtz, Todd R; Palmer, Julie R; Rosenberg, Lynn A et al. (2018) Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women. Cancer Epidemiol Biomarkers Prev 27:558-565
Kumar, Santosh; Suman, Shubhankar; Fornace Jr, Albert J et al. (2018) Space radiation triggers persistent stress response, increases senescent signaling, and decreases cell migration in mouse intestine. Proc Natl Acad Sci U S A 115:E9832-E9841
O'Neill, Suzanne C; Taylor, Kathryn L; Clapp, Jonathan et al. (2018) Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives. J Health Commun 23:679-686
Kim, Sang-Soo; Harford, Joe B; Moghe, Manish et al. (2018) Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Nucleic Acids Res 46:1424-1440
Laiakis, Evagelia C; Mak, Tytus D; Strawn, Steven J et al. (2018) Global metabolomic responses in urine from atm deficient mice in response to LD50/30 gamma irradiation doses. Environ Mol Mutagen 59:576-585
Wallington, Sherrie; Oppong, Bridget; Dash, Chiranjeev et al. (2018) A Community-Based Outreach Navigator Approach to Establishing Partnerships for a Safety Net Mammography Screening Center. J Cancer Educ 33:782-787

Showing the most recent 10 out of 1120 publications